The company’s technology uses non-invasive screenings for early detection based on over one million personalized health insights across its member base.

In today’s healthcare landscape, where treatment often begins only after a disease has been diagnosed, the importance of proactive, preventative care cannot be overstated. Prenuvo, a trailblazer in whole-body MRI screenings, is shifting the paradigm toward early detection, empowering people to take charge of their health before symptoms arise.

The company’s recent $120 million Series B funding round, co-led by Forerunner Ventures, Left Lane Capital, and Felicis, positions Prenuvo to expand its breakthrough preventative healthcare services that seek to detect silent killers such as cancer and aneurysms at their earliest stages.

Prenuvo’s innovative approach—using cutting-edge technology to offer comprehensive, non-invasive screenings—has already impacted the health space. The company currently identified over 1.4 million personalized health insights across its member base that emphasize the critical role of early detection in improving patient outcomes.

With over 110,000 members and FDA clearance for its AI-powered Prenuvo Body Composition report, Prenuvo is firmly establishing itself as a leader in the field of preventative healthcare.

A Visionary Approach to Health: Empowering Consumers for a Healthier Future

At the heart of Prenuvo’s mission is the desire to make proactive healthcare accessible to everyone. “Prenuvo is leading a movement to make proactive healthcare accessible and transformative for everyone,” said Andrew Lacy, CEO of Prenuvo Inc.

He emphasized the company’s vision of using cutting-edge technology and world-class expertise to shift the focus from treatment to prevention. “This isn’t just about healthcare; it’s about reimagining how we approach health, using technology to prevent disease and help people live longer, healthier lives.”

The concept of preventative care is becoming increasingly important as healthcare systems worldwide grapple with rising costs and an aging population. The traditional model often waits for symptoms to appear before intervention occurs, which may allow diseases to progress to more advanced and less treatable stages.

Prenuvo, however, provides individuals with the tools they need to detect potential health issues early, providing the opportunity to intervene before a problem becomes serious. This shift is changing the way consumers think about and approach their health.

Expanding Innovative Product Offerings

Prenuvo is making significant strides in enhancing its diagnostic offerings, which include whole-body MRI screenings, AI-powered body composition analysis, and more.

The company’s recent FDA clearance for its AI-powered Prenuvo Body Composition report is a major milestone, as it marks the introduction of a highly advanced, non-invasive platform that provides individuals with precise data on critical health metrics like visceral fat, liver fat, muscle volume, and the health of vital abdominal organs. This data empowers patients to make informed lifestyle choices and proactively address health concerns before they develop into larger problems.

Alongside the body composition report, Prenuvo has unveiled several groundbreaking new services:

  • AI-Powered Whole-Body Composition Analysis: This platform delivers quantitative data on various aspects of body health, including fat and muscle volumes, and provides actionable insights to patients for better lifestyle decisions.
  • Brain Health Scan: This scan offers critical insights into brain function and cognitive health, identifying early indicators of neurodegenerative conditions like Alzheimer’s and Parkinson’s offering patients the chance to intervene early.
  • Comprehensive Blood Bio-Marker Assessment: Prenuvo now offers a custom-built panel of blood tests that evaluate metabolic, cardiovascular, hormonal, and immune health. This new offering works synergistically with their imaging technologies to offer even deeper health insights.

These services will be rolled out to other regions in the coming months, including international locations in Europe and Australia. The bundled offering, called Prenuvo Enhanced, provides a holistic approach to healthcare, combining the latest in imaging technology with blood biomarker assessments to give patients an all-encompassing look at their health.

Building on Success: Prenuvo’s Rapid Growth and Clinical Excellence

Prenuvo’s growth trajectory is outstanding. In just a short time, the company has built the largest private radiology group focused solely on whole-body MRI, with over 80 board-certified radiologists on staff. This extensive clinical expertise has allowed Prenuvo to form valuable research collaborations with top academic institutions studying health, aging, and disease.

Unlike other healthcare providers, Prenuvo operates a fully vertically integrated model. This means they own and operate their MRI screening centers, ensuring complete control over every aspect of the patient experience—from scheduling to imaging to analysis.

With 17 centers already open across North America, Prenuvo plans to expand to 15 additional locations in the next year, including its first international clinics outside North America. This expansion will help meet the growing demand for preventative healthcare and further solidify Prenuvo’s position as a leader in the field.

Brian O’Malley from Forerunner emphasized the importance of Prenuvo’s unique approach to healthcare.

“With only 2.5% of healthcare spending focused on preventative medicine, the US system waits for people to become sick before intervening,” he said. “Prenuvo is the preeminent solution for a comprehensive understanding of one’s health, giving today’s patients unprecedented levels of knowledge to not just understand, but proactively intervene in the challenges that arise as we all age.”

A New Era for Preventative Healthcare

The rise of preventative health services like Prenuvo marks a turning point in how the public can think about wellness. By providing early detection, actionable insights, and empowering patients to take control of their health, Prenuvo is helping individuals take proactive steps toward healthier, longer lives.

As more consumers seek out innovative healthcare solutions that put them in control, Prenuvo’s continued growth and technological advancements will ensure that more people have access to this life-changing approach to health.

February 26, 2025